Triglav Skladi’s AbbVie ABBV Stock Holding History

Triglav Skladi’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.13M	Sell	23,600 -29,452	-56%	-$6.53M	0.36%	54
2025 Q4	$12.1M	Sell	53,052 -3,369	-6%	-$767K	0.77%	29
2025 Q3	$13.1M	Buy	56,421 +28,700	+104%	+$5.84M	0.85%	27
2025 Q2	$5.15M	Sell	27,721 -17,400	-39%	-$3.23M	0.37%	54
2025 Q1	$9.45M	Buy	45,121 +7,400	+20%	+$1.44M	0.79%	31
2024 Q4	$6.7M	Buy	+37,721	New	+$6.94M	0.53%	46

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Triglav Skladi's ABBV Position: Q1 2026 in Review

Triglav Skladi reduced its AbbVie (ABBV) stake by 56% in Q1 2026, selling an estimated $6.53M and leaving 23,600 shares worth $5.13M. The position accounts for 0.36% of the portfolio, ranked #54.

Triglav Skladi first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $13.1M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Triglav Skladi held 23,600 shares of AbbVie worth $5.13M as of Q1 2026.
Triglav Skladi sold 29,452 AbbVie shares in Q1 2026, an estimated $6.53M.
AbbVie made up 0.36% of Triglav Skladi's portfolio in Q1 2026, its #54 holding.
Triglav Skladi first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
Triglav Skladi's AbbVie position peaked at $13.1M in Q3 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Triglav Skladi's 13F filing for Q1 2026, filed 4 May 2026.